Technology
Health
Biotechnology

Sierra Oncology

$0.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0047 (-0.88%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SRRA and other stocks, options, ETFs, and crypto commission-free!

About SRRA

Sierra Oncology, Inc. Common Stock, also called Sierra Oncology, is a clinical stage drug development company of therapeutics for the treatment of patients with cancer. Read More It engages in the business of researching, developing, and commercializing therapies for the treatment of patients with cancer. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.

Employees
79
Headquarters
Vancouver, British Columbia
Founded
2003
Market Cap
39.94M
Price-Earnings Ratio
Dividend Yield
Average Volume
771.98K
High Today
$0.532
Low Today
$0.48
Open Price
$0.532
Volume
799.25K
52 Week High
$2.97
52 Week Low
$0.48

Collections

Technology
Health
Biotechnology
Cancer Prevention
Medical
Therapy
2015 IPO
Canada

SRRA Earnings

-$0.21
-$0.19
-$0.18
-$0.16
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.